GLP-1 and GIP receptor agonists in the treatment of Parkinson’s disease: Translational systematic review and meta-analysis protocol of clinical and preclinical studies

BACKGROUND: Parkinson’s disease (PD) is a progressive multifactorial neurodegenerative condition. Epidemiological studies have shown that patients with type 2 diabetes mellitus (T2DM2) are at increased risk for developing PD, indicating a possible insulin-modulating role in this latter condition. We...

Descripción completa

Detalles Bibliográficos
Autores principales: Vaccari, Carolina, Grotto, Denise, Pereira, Tiago da V., de Camargo, João Lauro V., Lopes, Luciane C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Registered Report Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8360366/
https://www.ncbi.nlm.nih.gov/pubmed/34383800
http://dx.doi.org/10.1371/journal.pone.0255726

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8360366/
https://www.ncbi.nlm.nih.gov/pubmed/34383800
http://dx.doi.org/10.1371/journal.pone.0255726

Ejemplares similares